{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T10:15:38Z","timestamp":1648635338668},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Foundation of Fujian Educational Committee","award":["JA15198"],"award-info":[{"award-number":["JA15198"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00277-017-3100-0","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T04:57:10Z","timestamp":1502945830000},"page":"1949-1951","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Somatic mutations of calreticulin in patients with myelodysplastic\/myeloproliferative neoplasms-unclassifiable"],"prefix":"10.1007","volume":"96","author":[{"given":"Xueya","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"3100_CR1","first-page":"75","volume-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","author":"S Swerdlow","year":"2008","unstructured":"Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (2008) WHO classification of tumors of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 75\u201386","edition":"4"},{"key":"3100_CR2","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","volume":"369","author":"T Klampfl","year":"2013","unstructured":"Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD et al (2013) Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 369:2379\u20132390","journal-title":"N Engl J Med"},{"key":"3100_CR3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","volume":"369","author":"J Nangalia","year":"2013","unstructured":"Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC et al (2013) Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369:2391\u20132405","journal-title":"N Engl J Med"},{"key":"3100_CR4","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2014-02-553800","volume":"123","author":"SA Wang","year":"2014","unstructured":"Wang SA, Hasserjian RP, Fox PS, Rogers HJ, Geyer JT, Chabot-Richards D et al (2014) Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic\/myeloproliferative neoplasms. Blood 123:2645\u20132651","journal-title":"Blood"},{"key":"3100_CR5","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1038\/bcj.2016.44","volume":"6","author":"D Barraco","year":"2016","unstructured":"Barraco D, Lasho TL, Gangat N, Finke C, Elala YC, Pardanani A et al (2016) Leukocytosis and presence of CALR mutation is associated with non-hepatosplenicextramedullary hematopoiesis in primary myelofibrosis. Blood Cancer J 6:e436","journal-title":"Blood Cancer J"},{"key":"3100_CR6","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/leu.2008.119","volume":"22","author":"A Orazi","year":"2008","unstructured":"Orazi A, Germing U (2008) The myelodysplastic\/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Leukemia 22:1308\u20131319","journal-title":"Leukemia"},{"key":"3100_CR7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/leu.2014.8","volume":"28","author":"CD DiNardo","year":"2014","unstructured":"DiNardo CD, Daver N, Jain N, Pemmaraju N, Bueso-Ramos C, Yin CC et al (2014) Myelodysplastic\/myeloproliferative neoplasms, unclassifiable (MDS\/MPN, U): natural history andclinical outcome by treatment strategy. Leukemia 28:958\u2013961","journal-title":"Leukemia"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-3100-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3100-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3100-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T16:14:32Z","timestamp":1508256872000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-3100-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":7,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3100"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-3100-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]}}}